Nacfc 2024 | W02: Agnostic Avenues: Alternatives To Cf Gene Therapy

NACFC 2024 | W02: Agnostic Avenues: Alternatives to CF Gene Therapy

Cystic Fibrosis Foundation

NACFC 2024 | W16: From the Gene Editor's Desk: Rewriting Mutant CFTR Using CRISPR and Other Tech

Cystic Fibrosis Foundation

NACFC 2024 | S15: Challenges to Efficient, Effective, and Durable CFTR Rescue

Cystic Fibrosis Foundation

NACFC 2024 | W32: Airway Differentiation, Pathogenesis, and Repair

Cystic Fibrosis Foundation

NACFC 2024 | DG08: Updates & Resources for Genetic Counseling for CF, CRMS/CFSPID

Cystic Fibrosis Foundation

CF Foundation | NACFC 2024 Highlights Webinar and Q+A

Cystic Fibrosis Foundation

NACFC 2024 | W03: New Insights Regarding CFTR Basic Biology and Implications for Future Therapeutics

Cystic Fibrosis Foundation

NACFC 2024 | S11: Nucleotide-Based Therapeutics Across Diverse Populations

Cystic Fibrosis Foundation

CF Foundation | Challenges & Progress in the Pursuit of Genetic Therapies for Cystic Fibrosis

Cystic Fibrosis Foundation

NACFC 2020: How Genetic-Based Therapies Could Restore CFTR Function

Cystic Fibrosis Foundation

NACFC 2024 | DG15: Emerging Topics in Cystic Fibrosis Genetics and Genetic Counseling

Cystic Fibrosis Foundation

NACFC 2023 | Genetic Therapies for All: Harnessing Cross-Disease Knowledge for Breakthroughs in CF

Cystic Fibrosis Foundation

NACFC 2024 | S23: Updates in CFTR Genetics

Cystic Fibrosis Foundation

NACFC 2024 | W28: Innovations in CF Pharmacotherapy

Cystic Fibrosis Foundation

NACFC 2022 | W36: Genetic and Cell-Based Approaches to Cystic Fibrosis Therapy

Cystic Fibrosis Foundation

NACFC 2024 | DG18: Explaining Research to New Populations

Cystic Fibrosis Foundation